Objectives: A combined equation based on white cell count (WCC) and total bilirubin (TB) was assessed for its ability to predict adverse clinical outcomes in patients with acute ST-segment elevation myocardial infarction (STEMI) with primary percutaneous coronary intervention (PCI).
Design: A single-centre, prospective cohort study.
Setting: The First Affiliated Hospital of Xinjiang Medical University.